Literature DB >> 25100892

Caffeine modifies blood glucose availability during prolonged low-intensity exercise in individuals with type-2 diabetes.

Luiz Augusto da Silva1, Leandro de Freitas2, Thiago Emannuel Medeiros2, Raul Osiecki3, Renan Garcia Michel4, André Luiz Snak5, Carlos Ricardo Maneck Malfatti5.   

Abstract

OBJECTIVE: The study investigated the effect of supplementation with maltodextrin (CHO) alone or associated to caffeine during exercise in T2DM subjects.
METHODS: Pilot study, using eight subjects with T2DM, aged 55±10 years, received CHO (1 g/kg) or caffeine (1.5 mg/kg) alone or associated before exercise protocol. The exercise was executed at 40% heart rate (HR) reserve for 40 min, with 10-min recovery. Blood pressure (BP) and perceived exertion scale (Borg) were checked every 2 min. Blood glucose (BG) was checked every 10 min. For statistical analysis, ANOVA test was used and the value was considered statistically significant at p <0.05.
RESULTS: The results showed that BP and HR did not change significantly among all treatments. Caffeine promoted a significant reduction in BG of 75 mg/dL (65%, p <0.05) during 40 min of exercise protocol compared to all groups.
CONCLUSION: Supplementation with 1.5 mg/kg of caffeine reduces BG concentration during prolonged exercise in T2DM patients.

Entities:  

Keywords:  Diabetes mellitus; caffeine; exercise; supplementary feeding

Mesh:

Substances:

Year:  2014        PMID: 25100892      PMCID: PMC4123585     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN: 0120-8322


  27 in total

1.  Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats.

Authors:  Silvia V Conde; Tiago Nunes da Silva; Constancio Gonzalez; Miguel Mota Carmo; Emilia C Monteiro; Maria P Guarino
Journal:  Br J Nutr       Date:  2011-06-23       Impact factor: 3.718

2.  Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent signal for insulin secretion.

Authors:  Joseph D Bruton; Raf Lemmens; Chun-Liang Shi; Solveig Persson-Sjögren; Håkan Westerblad; Masroor Ahmed; Nigel J Pyne; Mhairi Frame; Brian L Furman; Md Shahidul Islam
Journal:  FASEB J       Date:  2002-12-03       Impact factor: 5.191

3.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

Review 4.  Coffee, caffeine and blood pressure: a critical review.

Authors:  M L Nurminen; L Niittynen; R Korpela; H Vapaatalo
Journal:  Eur J Clin Nutr       Date:  1999-11       Impact factor: 4.016

5.  Caffeine can decrease insulin sensitivity in humans.

Authors:  Gerben B Keijzers; Bastiaan E De Galan; Cees J Tack; Paul Smits
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

6.  Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

Authors:  Louis Monnier; Hélène Lapinski; Claude Colette
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

Review 7.  Caffeine and exercise.

Authors:  Scott A Paluska
Journal:  Curr Sports Med Rep       Date:  2003-08       Impact factor: 1.733

8.  Rate of starch hydrolysis in vitro as a predictor of metabolic responses to complex carbohydrate in vivo.

Authors:  K O'Dea; P Snow; P Nestel
Journal:  Am J Clin Nutr       Date:  1981-10       Impact factor: 7.045

9.  Coffee consumption and risk for type 2 diabetes mellitus.

Authors:  Eduardo Salazar-Martinez; Walter C Willett; Alberto Ascherio; JoAnn E Manson; Michael F Leitzmann; Meir J Stampfer; Frank B Hu
Journal:  Ann Intern Med       Date:  2004-01-06       Impact factor: 25.391

10.  Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes.

Authors:  Nobuyuki Yasuda; Takashi Inoue; Tatsuo Horizoe; Kaya Nagata; Hiroe Minami; Tsutomu Kawata; Yorihisa Hoshino; Hitoshi Harada; Seiji Yoshikawa; Osamu Asano; Junsaku Nagaoka; Manabu Murakami; Shinya Abe; Seiichi Kobayashi; Isao Tanaka
Journal:  Eur J Pharmacol       Date:  2003-01-17       Impact factor: 4.432

View more
  3 in total

Review 1.  Caffeine in Kidney Stone Disease: Risk or Benefit?

Authors:  Paleerath Peerapen; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

Review 2.  Caffeine and cardiovascular diseases: critical review of current research.

Authors:  Anthony Zulli; Renee M Smith; Peter Kubatka; Jan Novak; Yoshio Uehara; Hayley Loftus; Tawar Qaradakhi; Miroslav Pohanka; Nazarii Kobyliak; Angela Zagatina; Jan Klimas; Alan Hayes; Giampiero La Rocca; Miroslav Soucek; Peter Kruzliak
Journal:  Eur J Nutr       Date:  2016-03-01       Impact factor: 5.614

Review 3.  Beneficial Impact of Semicarbazide-Sensitive Amine Oxidase Inhibition on the Potential Cytotoxicity of Creatine Supplementation in Type 2 Diabetes Mellitus.

Authors:  Dimitri Papukashvili; Nino Rcheulishvili; Yulin Deng
Journal:  Molecules       Date:  2020-04-27       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.